nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—NAT2—head and neck cancer	0.747	1	CbGaD
Sulfamethoxazole—ALB—Fluorouracil—head and neck cancer	0.0325	0.352	CbGbCtD
Sulfamethoxazole—CYP2C8—Fluorouracil—head and neck cancer	0.0251	0.272	CbGbCtD
Sulfamethoxazole—CYP2C9—Fluorouracil—head and neck cancer	0.0175	0.19	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinblastine—head and neck cancer	0.00942	0.102	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—head and neck cancer	0.00777	0.0842	CbGbCtD
Sulfamethoxazole—Anaemia megaloblastic—Hydroxyurea—head and neck cancer	0.00409	0.0693	CcSEcCtD
Sulfamethoxazole—NAT1—Phase II conjugation—NAT2—head and neck cancer	0.00298	0.0297	CbGpPWpGaD
Sulfamethoxazole—Lung infiltration—Hydroxyurea—head and neck cancer	0.00205	0.0348	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—NAT2—head and neck cancer	0.00174	0.0174	CbGpPWpGaD
Sulfamethoxazole—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00174	0.0295	CcSEcCtD
Sulfamethoxazole—Eruption—Hydroxyurea—head and neck cancer	0.00156	0.0266	CcSEcCtD
Sulfamethoxazole—Drug fever—Docetaxel—head and neck cancer	0.0015	0.0254	CcSEcCtD
Sulfamethoxazole—NAT1—Phase II conjugation—GSTM1—head and neck cancer	0.00147	0.0147	CbGpPWpGaD
Sulfamethoxazole—Digestion impaired—Hydroxyurea—head and neck cancer	0.00144	0.0244	CcSEcCtD
Sulfamethoxazole—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00143	0.0242	CcSEcCtD
Sulfamethoxazole—Neuritis—Vinblastine—head and neck cancer	0.00141	0.024	CcSEcCtD
Sulfamethoxazole—Dapsone—NAT2—head and neck cancer	0.00108	0.849	CrCbGaD
Sulfamethoxazole—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00102	0.0173	CcSEcCtD
Sulfamethoxazole—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.000903	0.0153	CcSEcCtD
Sulfamethoxazole—NAT1—Biological oxidations—GSTM1—head and neck cancer	0.000861	0.00859	CbGpPWpGaD
Sulfamethoxazole—NAT1—Biological oxidations—CYP1A1—head and neck cancer	0.000816	0.00815	CbGpPWpGaD
Sulfamethoxazole—Eruption—Docetaxel—head and neck cancer	0.000813	0.0138	CcSEcCtD
Sulfamethoxazole—UGT1A9—Estrogen metabolism—GSTM1—head and neck cancer	0.000757	0.00755	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000723	0.00721	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—UROD—head and neck cancer	0.000718	0.00716	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Estrogen metabolism—CYP1A1—head and neck cancer	0.000718	0.00716	CbGpPWpGaD
Sulfamethoxazole—Neuritis—Docetaxel—head and neck cancer	0.00067	0.0114	CcSEcCtD
Sulfamethoxazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000658	0.00657	CbGpPWpGaD
Sulfamethoxazole—Pancytopenia—Vinblastine—head and neck cancer	0.000629	0.0107	CcSEcCtD
Sulfamethoxazole—NAT2—Phase II conjugation—GSTM1—head and neck cancer	0.000611	0.0061	CbGpPWpGaD
Sulfamethoxazole—Pancreatitis—Hydroxyurea—head and neck cancer	0.000592	0.01	CcSEcCtD
Sulfamethoxazole—Depression—Vinblastine—head and neck cancer	0.000589	0.00999	CcSEcCtD
Sulfamethoxazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000588	0.00587	CbGpPWpGaD
Sulfamethoxazole—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000579	0.00982	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Hydroxyurea—head and neck cancer	0.000574	0.00973	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Fluorouracil—head and neck cancer	0.000573	0.00972	CcSEcCtD
Sulfamethoxazole—Neutropenia—Hydroxyurea—head and neck cancer	0.000565	0.00958	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Vinblastine—head and neck cancer	0.000551	0.00935	CcSEcCtD
Sulfamethoxazole—Oliguria—Docetaxel—head and neck cancer	0.000543	0.00921	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Hydroxyurea—head and neck cancer	0.000539	0.00914	CcSEcCtD
Sulfamethoxazole—Infestation—Hydroxyurea—head and neck cancer	0.000539	0.00914	CcSEcCtD
Sulfamethoxazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000536	0.00534	CbGpPWpGaD
Sulfamethoxazole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000528	0.00896	CcSEcCtD
Sulfamethoxazole—Stomatitis—Hydroxyurea—head and neck cancer	0.000525	0.00891	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000509	0.00864	CcSEcCtD
Sulfamethoxazole—Hallucination—Hydroxyurea—head and neck cancer	0.000481	0.00816	CcSEcCtD
Sulfamethoxazole—Ataxia—Fluorouracil—head and neck cancer	0.000473	0.00802	CcSEcCtD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.000462	0.00461	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000456	0.00454	CbGpPWpGaD
Sulfamethoxazole—Chills—Hydroxyurea—head and neck cancer	0.000434	0.00736	CcSEcCtD
Sulfamethoxazole—UGT1A9—Phase II conjugation—NAT2—head and neck cancer	0.000431	0.0043	CbGpPWpGaD
Sulfamethoxazole—Eosinophilia—Fluorouracil—head and neck cancer	0.00043	0.0073	CcSEcCtD
Sulfamethoxazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.000425	0.00424	CbGpPWpGaD
Sulfamethoxazole—Vertigo—Vinblastine—head and neck cancer	0.000415	0.00703	CcSEcCtD
Sulfamethoxazole—Leukopenia—Vinblastine—head and neck cancer	0.000413	0.00701	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Fluorouracil—head and neck cancer	0.000413	0.007	CcSEcCtD
Sulfamethoxazole—Convulsion—Vinblastine—head and neck cancer	0.0004	0.00678	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000397	0.00673	CcSEcCtD
Sulfamethoxazole—Pneumonia—Fluorouracil—head and neck cancer	0.00039	0.00661	CcSEcCtD
Sulfamethoxazole—Infestation—Fluorouracil—head and neck cancer	0.000388	0.00658	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Fluorouracil—head and neck cancer	0.000388	0.00658	CcSEcCtD
Sulfamethoxazole—Renal impairment—Docetaxel—head and neck cancer	0.000381	0.00647	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00038	0.00645	CcSEcCtD
Sulfamethoxazole—Stomatitis—Fluorouracil—head and neck cancer	0.000378	0.00641	CcSEcCtD
Sulfamethoxazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000377	0.00639	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000369	0.00626	CcSEcCtD
Sulfamethoxazole—Convulsion—Hydroxyurea—head and neck cancer	0.000365	0.00619	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Docetaxel—head and neck cancer	0.000364	0.00618	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000362	0.00614	CcSEcCtD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000361	0.0036	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Vinblastine—head and neck cancer	0.000359	0.00609	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—GSTM1—head and neck cancer	0.000358	0.00357	CbGpPWpGaD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000356	0.00604	CcSEcCtD
Sulfamethoxazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000353	0.00352	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000353	0.00352	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000351	0.0035	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000347	0.00347	CbGpPWpGaD
Sulfamethoxazole—Ataxia—Docetaxel—head and neck cancer	0.000341	0.00579	CcSEcCtD
Sulfamethoxazole—NAT2—Biological oxidations—CYP1A1—head and neck cancer	0.000339	0.00338	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000339	0.00338	CbGpPWpGaD
Sulfamethoxazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000337	0.00571	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000336	0.00571	CcSEcCtD
Sulfamethoxazole—NAT2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000334	0.00334	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000334	0.00333	CbGpPWpGaD
Sulfamethoxazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000334	0.00566	CcSEcCtD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.000333	0.00332	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Hydroxyurea—head and neck cancer	0.000327	0.00555	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vinblastine—head and neck cancer	0.000327	0.00555	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000327	0.00555	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000308	0.00522	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000306	0.0052	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000302	0.00513	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—YAP1—head and neck cancer	0.0003	0.00299	CbGpPWpGaD
Sulfamethoxazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000299	0.00507	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—UROD—head and neck cancer	0.000298	0.00298	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—NAT2—head and neck cancer	0.000298	0.00298	CbGpPWpGaD
Sulfamethoxazole—Pancytopenia—Docetaxel—head and neck cancer	0.000298	0.00506	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vinblastine—head and neck cancer	0.000298	0.00505	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000297	0.00503	CcSEcCtD
Sulfamethoxazole—Fatigue—Hydroxyurea—head and neck cancer	0.000296	0.00502	CcSEcCtD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.000293	0.00293	CbGpPWpGaD
Sulfamethoxazole—Neutropenia—Docetaxel—head and neck cancer	0.000293	0.00498	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—CCND1—head and neck cancer	0.000287	0.00287	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000283	0.00282	CbGpPWpGaD
Sulfamethoxazole—Pneumonia—Docetaxel—head and neck cancer	0.000281	0.00477	CcSEcCtD
Sulfamethoxazole—Infestation—Docetaxel—head and neck cancer	0.00028	0.00475	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Docetaxel—head and neck cancer	0.00028	0.00475	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vinblastine—head and neck cancer	0.000277	0.00471	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000277	0.00471	CcSEcCtD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000276	0.00276	CbGpPWpGaD
Sulfamethoxazole—Renal failure—Docetaxel—head and neck cancer	0.000275	0.00467	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000274	0.00465	CcSEcCtD
Sulfamethoxazole—Stomatitis—Docetaxel—head and neck cancer	0.000273	0.00463	CcSEcCtD
Sulfamethoxazole—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000272	0.00271	CbGpPWpGaD
Sulfamethoxazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000272	0.00461	CcSEcCtD
Sulfamethoxazole—Leukopenia—Fluorouracil—head and neck cancer	0.000271	0.0046	CcSEcCtD
Sulfamethoxazole—Asthenia—Vinblastine—head and neck cancer	0.00027	0.00458	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000265	0.00449	CcSEcCtD
Sulfamethoxazole—Convulsion—Fluorouracil—head and neck cancer	0.000262	0.00445	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—DPYD—head and neck cancer	0.000261	0.00261	CbGpPWpGaD
Sulfamethoxazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000261	0.00443	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000261	0.0026	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000258	0.00258	CbGpPWpGaD
Sulfamethoxazole—Myalgia—Fluorouracil—head and neck cancer	0.000258	0.00438	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vinblastine—head and neck cancer	0.000258	0.00437	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000253	0.00429	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—NAT2—head and neck cancer	0.000252	0.00251	CbGpPWpGaD
Sulfamethoxazole—Hepatitis—Docetaxel—head and neck cancer	0.000251	0.00426	CcSEcCtD
Sulfamethoxazole—Dizziness—Vinblastine—head and neck cancer	0.000249	0.00423	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—NAT2—head and neck cancer	0.000249	0.00248	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—YAP1—head and neck cancer	0.000248	0.00248	CbGpPWpGaD
Sulfamethoxazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000248	0.00421	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000247	0.00419	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.000247	0.00419	CcSEcCtD
Sulfamethoxazole—Asthenia—Hydroxyurea—head and neck cancer	0.000246	0.00418	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Docetaxel—head and neck cancer	0.000246	0.00418	CcSEcCtD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFA—head and neck cancer	0.000244	0.00244	CbGpPWpGaD
Sulfamethoxazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.000242	0.00411	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000242	0.00411	CcSEcCtD
Sulfamethoxazole—Vomiting—Vinblastine—head and neck cancer	0.000239	0.00406	CcSEcCtD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000238	0.00238	CbGpPWpGaD
Sulfamethoxazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000237	0.00403	CcSEcCtD
Sulfamethoxazole—Headache—Vinblastine—head and neck cancer	0.000236	0.004	CcSEcCtD
Sulfamethoxazole—Anorexia—Fluorouracil—head and neck cancer	0.000236	0.004	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000235	0.00399	CcSEcCtD
Sulfamethoxazole—Eye disorder—Docetaxel—head and neck cancer	0.000235	0.00398	CcSEcCtD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000231	0.00231	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Hydroxyurea—head and neck cancer	0.000227	0.00385	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Docetaxel—head and neck cancer	0.000227	0.00385	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.000226	0.00384	CcSEcCtD
Sulfamethoxazole—Chills—Docetaxel—head and neck cancer	0.000225	0.00382	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000225	0.00382	CcSEcCtD
Sulfamethoxazole—Nausea—Vinblastine—head and neck cancer	0.000224	0.0038	CcSEcCtD
Sulfamethoxazole—Insomnia—Fluorouracil—head and neck cancer	0.000224	0.00379	CcSEcCtD
Sulfamethoxazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000223	0.00222	CbGpPWpGaD
Sulfamethoxazole—Dyspnoea—Fluorouracil—head and neck cancer	0.00022	0.00374	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—head and neck cancer	0.00022	0.00373	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—head and neck cancer	0.000219	0.00371	CcSEcCtD
Sulfamethoxazole—Vomiting—Hydroxyurea—head and neck cancer	0.000218	0.0037	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000218	0.00369	CcSEcCtD
Sulfamethoxazole—Rash—Hydroxyurea—head and neck cancer	0.000217	0.00367	CcSEcCtD
Sulfamethoxazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000216	0.00367	CcSEcCtD
Sulfamethoxazole—Headache—Hydroxyurea—head and neck cancer	0.000215	0.00365	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000215	0.00365	CcSEcCtD
Sulfamethoxazole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000214	0.00213	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000213	0.00362	CcSEcCtD
Sulfamethoxazole—UGT1A9—Phase II conjugation—GSTM1—head and neck cancer	0.000213	0.00212	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000205	0.00205	CbGpPWpGaD
Sulfamethoxazole—Nausea—Hydroxyurea—head and neck cancer	0.000204	0.00346	CcSEcCtD
Sulfamethoxazole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000203	0.00202	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000202	0.00202	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Fluorouracil—head and neck cancer	0.000196	0.00333	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—head and neck cancer	0.000196	0.00332	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000195	0.00332	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—head and neck cancer	0.000192	0.151	CrCbGaD
Sulfamethoxazole—Cough—Docetaxel—head and neck cancer	0.000191	0.00324	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—head and neck cancer	0.000189	0.00321	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000187	0.00186	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000186	0.00186	CbGpPWpGaD
Sulfamethoxazole—Arthralgia—Docetaxel—head and neck cancer	0.000186	0.00316	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—head and neck cancer	0.000186	0.00316	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000185	0.00314	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000182	0.00309	CcSEcCtD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000181	0.00181	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000179	0.00179	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000178	0.00303	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—head and neck cancer	0.000175	0.00297	CcSEcCtD
Sulfamethoxazole—Pruritus—Fluorouracil—head and neck cancer	0.000175	0.00297	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000175	0.00296	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000174	0.00174	CbGpPWpGaD
Sulfamethoxazole—Skin disorder—Docetaxel—head and neck cancer	0.000173	0.00294	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.000173	0.00173	CbGpPWpGaD
Sulfamethoxazole—Anorexia—Docetaxel—head and neck cancer	0.00017	0.00289	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Fluorouracil—head and neck cancer	0.000169	0.00287	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000169	0.00168	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000169	0.00168	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000167	0.00167	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000166	0.00166	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.000165	0.00165	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Fluorouracil—head and neck cancer	0.000163	0.00277	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000163	0.00276	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—head and neck cancer	0.000161	0.00274	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—head and neck cancer	0.000159	0.0027	CcSEcCtD
Sulfamethoxazole—Vomiting—Fluorouracil—head and neck cancer	0.000157	0.00267	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—head and neck cancer	0.000157	0.00266	CcSEcCtD
Sulfamethoxazole—Rash—Fluorouracil—head and neck cancer	0.000156	0.00264	CcSEcCtD
Sulfamethoxazole—Dermatitis—Fluorouracil—head and neck cancer	0.000156	0.00264	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—head and neck cancer	0.000155	0.00263	CcSEcCtD
Sulfamethoxazole—Headache—Fluorouracil—head and neck cancer	0.000155	0.00263	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000154	0.00261	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—head and neck cancer	0.000154	0.00261	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000154	0.00153	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—TYMS—head and neck cancer	0.000149	0.00149	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—GSTM1—head and neck cancer	0.000147	0.00147	CbGpPWpGaD
Sulfamethoxazole—Nausea—Fluorouracil—head and neck cancer	0.000147	0.00249	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000146	0.00248	CcSEcCtD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000144	0.00144	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000143	0.00143	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000142	0.00142	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—GSTM1—head and neck cancer	0.000142	0.00142	CbGpPWpGaD
Sulfamethoxazole—Body temperature increased—Docetaxel—head and neck cancer	0.000141	0.00239	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—head and neck cancer	0.000141	0.00239	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—GPX1—head and neck cancer	0.000141	0.00141	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000141	0.0014	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CYP1A1—head and neck cancer	0.00014	0.00139	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000137	0.00137	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000136	0.00136	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000134	0.00134	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000133	0.00132	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000131	0.00223	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000131	0.00131	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Docetaxel—head and neck cancer	0.000128	0.00217	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—head and neck cancer	0.000126	0.00214	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.000124	0.00124	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000123	0.00122	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Docetaxel—head and neck cancer	0.000122	0.00207	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—head and neck cancer	0.000118	0.002	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.00118	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000117	0.00117	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000117	0.00117	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000116	0.00116	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000116	0.00116	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000114	0.00113	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Docetaxel—head and neck cancer	0.000113	0.00192	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—head and neck cancer	0.000113	0.00191	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—head and neck cancer	0.000112	0.00191	CcSEcCtD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000112	0.00112	CbGpPWpGaD
Sulfamethoxazole—Headache—Docetaxel—head and neck cancer	0.000112	0.0019	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—DPYD—head and neck cancer	0.000109	0.00108	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000108	0.00108	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000107	0.00106	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000106	0.00106	CbGpPWpGaD
Sulfamethoxazole—Nausea—Docetaxel—head and neck cancer	0.000106	0.0018	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metabolism—UROD—head and neck cancer	0.000104	0.00104	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—YAP1—head and neck cancer	0.000103	0.00103	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000101	0.00101	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.93e-05	0.00099	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	9.78e-05	0.000975	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	9.62e-05	0.000959	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.58e-05	0.000955	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.52e-05	0.00095	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—UROD—head and neck cancer	8.46e-05	0.000844	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTGS2—head and neck cancer	8.3e-05	0.000828	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.08e-05	0.000806	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.05e-05	0.000803	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.74e-05	0.000772	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.64e-05	0.000762	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—head and neck cancer	7.33e-05	0.000731	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTEN—head and neck cancer	7.24e-05	0.000722	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.12e-05	0.00071	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.02e-05	0.000701	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.56e-05	0.000655	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	6.55e-05	0.000654	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	6.46e-05	0.000645	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	6.28e-05	0.000626	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.28e-05	0.000626	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	6.21e-05	0.00062	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—TYMS—head and neck cancer	6.19e-05	0.000617	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	6.13e-05	0.000611	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GSTM1—head and neck cancer	6.12e-05	0.00061	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.09e-05	0.000608	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—GPX1—head and neck cancer	5.86e-05	0.000584	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP1A1—head and neck cancer	5.8e-05	0.000578	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	5.49e-05	0.000548	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—UROD—head and neck cancer	5.46e-05	0.000545	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—UROD—head and neck cancer	5.43e-05	0.000542	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—head and neck cancer	5.34e-05	0.000533	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.33e-05	0.000532	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.26e-05	0.000525	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CA—head and neck cancer	5.11e-05	0.00051	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	5.09e-05	0.000507	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	5.06e-05	0.000504	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	4.99e-05	0.000497	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—head and neck cancer	4.7e-05	0.000469	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.58e-05	0.000457	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.53e-05	0.000452	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—UROD—head and neck cancer	4.45e-05	0.000444	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NAT2—head and neck cancer	4.31e-05	0.00043	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.24e-05	0.000423	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.22e-05	0.000421	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—AKT1—head and neck cancer	4.17e-05	0.000416	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—DPYD—head and neck cancer	3.78e-05	0.000377	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.73e-05	0.000372	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.69e-05	0.000368	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—YAP1—head and neck cancer	3.59e-05	0.000358	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.52e-05	0.000351	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NAT2—head and neck cancer	3.51e-05	0.00035	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.47e-05	0.000346	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.45e-05	0.000344	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—head and neck cancer	3.45e-05	0.000344	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.33e-05	0.000333	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.29e-05	0.000328	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—DPYD—head and neck cancer	3.08e-05	0.000307	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—head and neck cancer	3.01e-05	0.0003	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UROD—head and neck cancer	2.93e-05	0.000293	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—YAP1—head and neck cancer	2.92e-05	0.000292	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	2.79e-05	0.000278	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.69e-05	0.000269	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.41e-05	0.00024	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.4e-05	0.000239	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.39e-05	0.000238	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.37e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	2.37e-05	0.000236	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.35e-05	0.000234	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NAT2—head and neck cancer	2.27e-05	0.000226	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NAT2—head and neck cancer	2.26e-05	0.000225	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.24e-05	0.000223	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.2e-05	0.000219	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TYMS—head and neck cancer	2.15e-05	0.000215	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.13e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.000212	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—head and neck cancer	2.12e-05	0.000212	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000203	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000201	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—DPYD—head and neck cancer	1.99e-05	0.000198	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—DPYD—head and neck cancer	1.98e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.96e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.94e-05	0.000194	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.92e-05	0.000191	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—YAP1—head and neck cancer	1.89e-05	0.000188	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—YAP1—head and neck cancer	1.88e-05	0.000187	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.85e-05	0.000184	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NAT2—head and neck cancer	1.85e-05	0.000184	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TYMS—head and neck cancer	1.76e-05	0.000175	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—head and neck cancer	1.73e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—head and neck cancer	1.73e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—head and neck cancer	1.66e-05	0.000166	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.66e-05	0.000165	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.64e-05	0.000164	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—DPYD—head and neck cancer	1.62e-05	0.000162	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—YAP1—head and neck cancer	1.54e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.51e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—head and neck cancer	1.44e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.42e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.41e-05	0.000141	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.35e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.24e-05	0.000123	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.23e-05	0.000123	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—head and neck cancer	1.22e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAT2—head and neck cancer	1.22e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.00012	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.15e-05	0.000115	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—head and neck cancer	1.15e-05	0.000115	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—head and neck cancer	1.13e-05	0.000113	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—head and neck cancer	1.13e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—head and neck cancer	1.11e-05	0.000111	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—head and neck cancer	1.1e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000107	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DPYD—head and neck cancer	1.07e-05	0.000107	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000105	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—YAP1—head and neck cancer	1.01e-05	0.000101	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.01e-05	0.0001	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—head and neck cancer	9.78e-06	9.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—head and neck cancer	9.53e-06	9.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—head and neck cancer	9.23e-06	9.21e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—head and neck cancer	9.22e-06	9.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	9.12e-06	9.1e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—head and neck cancer	8.82e-06	8.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—head and neck cancer	8.73e-06	8.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.73e-06	8.71e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.68e-06	8.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	8.65e-06	8.63e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—head and neck cancer	8.53e-06	8.51e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—head and neck cancer	7.79e-06	7.77e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—head and neck cancer	7.38e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.1e-06	7.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—head and neck cancer	6.32e-06	6.3e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—head and neck cancer	6.28e-06	6.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—head and neck cancer	6.09e-06	6.07e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—head and neck cancer	6.03e-06	6.02e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—head and neck cancer	6.02e-06	6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.01e-06	6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—head and neck cancer	5.76e-06	5.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.7e-06	5.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—head and neck cancer	5.51e-06	5.5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—head and neck cancer	5.48e-06	5.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.14e-06	5.13e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—head and neck cancer	4.92e-06	4.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—head and neck cancer	4.48e-06	4.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—head and neck cancer	3.89e-06	3.88e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—head and neck cancer	3.86e-06	3.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.39e-06	3.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—head and neck cancer	3.18e-06	3.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.16e-06	3.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—head and neck cancer	3.16e-06	3.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—head and neck cancer	2.96e-06	2.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—head and neck cancer	2.58e-06	2.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.09e-06	2.08e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—head and neck cancer	1.7e-06	1.7e-05	CbGpPWpGaD
